Bio-Techne Corp

TECH: XNAS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
w#LOCK|FM!@>LOCK|N@#Bn<RX

Bio-Techne Earnings: Strong Growth in Protein Sciences, but US Academic Market Uncertain

Bio-Techne reported fiscal third-quarter organic revenue growth of 6% year on year, consisting of 7% organic growth in protein sciences and 2% in diagnostics and spatial biology. Adjusted operating margin was 34.9%, a 1.9-percentage-point improvement over the year-ago period.

Sponsor Center